MITRASSIST
MitrAssist introduces a minimally invasive approach to MR treatment. Its mitral valve implant works in unison with the natural mitral valve without harming its functionality. MitrAssist has developed a new approach to treating MR that is neither repair nor replacement. Instead, its proprietary valve implant is placed on top of the natural valve to work in unison with it and to enhance valve functionality. MitrAssist’s “valve-in-valve” approach overcomes the various challenges of MR and offers an improved treatment solution for all MR patients. It has significant advantages over minimally invasive solutions – both existing and in development.
MITRASSIST
Industry:
Biotechnology Health Diagnostics Pharmaceutical
Founded:
2009-01-01
Address:
Misgav Dov, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.mitrassist.com
Total Employee:
1+
Status:
Active
Contact:
972.260.7000
Email Addresses:
[email protected]
Total Funding:
81 M USD
Technology used in webpage:
Google Analytics Google Analytics Classic
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Current Employees Featured
Founder
Investors List
CICC Healthcare Investment Fund
CICC Healthcare Investment Fund investment in Venture Round - MitrAssist
6 Dimensions Capital
6 Dimensions Capital investment in Venture Round - MitrAssist
Centurium Capital
Centurium Capital investment in Venture Round - MitrAssist
CITIC Capital Holdings
CITIC Capital Holdings investment in Venture Round - MitrAssist
Fosun Pharma
Fosun Pharma investment in Venture Round - MitrAssist
Ping An
Ping An investment in Venture Round - MitrAssist
Fosun International
Fosun International investment in Venture Round - MitrAssist
Ping An
Ping An investment in Venture Round - MitrAssist
Trendlines Group
Trendlines Group investment in Angel Round - MitrAssist
Official Site Inspections
http://www.mitrassist.com
- Host name: ns15.secured.co.il
- IP address: 192.114.144.83
- Location: Israel
- Latitude: 31.5
- Longitude: 34.75
- Timezone: Asia/Jerusalem
More informations about "MitrAssist"
MitrAssist - Crunchbase Company Profile & Funding
MitrAssist introduces a minimally invasive approach to MR treatment. Its mitral valve implant works in unison with the natural mitral valve without harming its functionality. MitrAssist has …See details»
Mitrassist
MitrAssist introduces a minimally invasive approach to MR treatment. Its mitral valve implant works in unison with the natural mitral valve without harming its functionality. dramatically decreases the length of the procedure and patients’ …See details»
MitrAssist Company Profile 2024: Valuation, Investors
Manufacturer of a cardiac implant intended for the treatment of mitral valve regurgitation (MR).See details»
MitrAssist (China) Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for MitrAssist (China). Use the PitchBook Platform to explore the full profile.See details»
Mitrassist - nanagement Team
MitrAssist is led by a highly experienced, qualified team.See details»
MitrAssist - Products, Competitors, Financials, Employees, …
MitrAssist focuses on cardiology in the healthcare industry. The company offers a minimally invasive mitral valve implant that works in conjunction with the patient's natural mitral valve to …See details»
MitrAssist - Foreign Startup | Startup Nation Finder
Nov 9, 2017 · MitrAssist has developed an approach to treating patients with life-threatening mitral regurgitation (MR) that involves neither repair nor replacement. Instead, the companys …See details»
MitrAssist - LinkedIn
MitrAssist is a promising startup in the cardiology field. Our mission is to provide a safe and minimal invasive solution for the treatment of every patient suffering from mitral regurgitation...See details»
MitrAssist - Funding, Financials, Valuation & Investors - Crunchbase
MitrAssist offers a minimally invasive approach to mitral regurgitation treatment.See details»
MitraAssist Company Profile - Office Locations, Competitors ... - Craft
MitraAssist has 5 employees at their 1 location. See insights on MitraAssist including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
MitrAssist - VentureRadar
Website: http://mitrassist.com. Develops a unique approach to treating Mitral Regurgitation through a proprietary valve implant that enhances natural valve functionality. VentureRadar …See details»
MitrAssist - The Trendlines Group
MitrAssist has developed a minimally invasive approach to treating mitral regurgitation (MR). The proprietary MitrAssist implant is placed on top of the heart’s own mitral valve and works in …See details»
AdjuCor Raises € 29 Million in Series B Funding Round for its ...
MitrAssist Holdings Limited, founded in 2009, is a global interventional cardiovascular device platform company with an established track record of global premium partnership, R&D and …See details»
MitrAssist - Minimally Invasive Treatment for Mitral Regurgitation ...
Find out more about MitrAssist's founders and team members at Start-Up Nation Finder!See details»
The Product - Mitrassist
MitrAssist’s “valve-in-valve” approach overcomes the various challenges of MR and offers an improved treatment solution for all MR patients. It has significant advantages over minimally …See details»
Chinese Cardiovascular Medical Device Maker MitrAssist Bags …
(Yicai) Sept. 28 -- MitrAssist, a Chinese innovative cardiovascular medical device maker, has raised USD100 million in its latest financing round. The Series C fundraiser was led by …See details»
Percutaneous Transcatheter Mitral Valve Replacement:
Jun 1, 2014 · MitrAssist Medical Ltd (Misgav, Israel) has developed an approach for the treatment of MR that is neither repair nor replacement. Instead, its valve implant is placed on top of the …See details»
Mitrassist - Opportunity
MitrAssist estimates the annual potential U.S. market opportunity for newly diagnosed, untreated acute patients at $1.5 billion (based on average device costs). Treatment for MR is moving …See details»
Clinical Application of a Fully Ultrasound-Guided Transapical ...
The MitraFix valve (MitrAssist Lifesciences, Shanghai, China) consists of a D-shaped nitinol frame and 3 bovine pericardium leaflets (Figures 1A and 1B). The 30-F transapical delivery system …See details»
The Need - Mitrassist
MR is the most common type of heart valve disease. It occurs when the mitral valve’s leaflets are not sealed tightly, and blood leaks backward from the left ventricle into the left atrium instead …See details»